This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignee: Cj Cheiljedang Corporation. Active years: 2015-2024.
Company Filing History:
Years Active: 2015-2024
Title: Innovations and Contributions of Inventor Ju Jeong Kim
Introduction
Ju Jeong Kim is a distinguished inventor based in Suwon-si, South Korea. He holds an impressive portfolio of six patents, showcasing his dedication to scientific progress and innovation. Kim's work primarily focuses on biochemistry and the production of vital compounds, contributing significantly to the fields of biotechnology and pharmaceuticals.
Latest Patents
Among his latest inventions, Ju Jeong Kim has developed a novel polypeptide that demonstrates an important function in exporting 5′-inosine monophosphate (IMP). This groundbreaking innovation includes a microorganism that incorporates the polypeptide and outlines a method for preparing 5′-inosine monophosphate efficiently. The invention also presents strategies on how to enhance the export of 5′-inosine monophosphate, presenting potential applications in various industries reliant on this crucial compound.
Career Highlights
Ju Jeong Kim currently works at CJ Cheiljedang Corporation, a leading company in the food and biotechnology sectors. His role involves leveraging his expertise in biotechnology to drive product development and innovation, as well as contributing to the company's overall research objectives. Through his dedication and innovative spirit, Kim has significantly impacted his organization and the wider scientific community.
Collaborations
Throughout his career, Ju Jeong Kim has collaborated with notable colleagues such as Min Ji Baek and Jung Gun Kwon. These partnerships have been instrumental in enhancing his research initiatives and further driving the innovative projects at CJ Cheiljedang Corporation.
Conclusion
Ju Jeong Kim stands out as a key contributor to the field of biotechnology, with his inventive mindset and collaborative efforts leading to valuable advancements. His work not only benefits his organization but also presents potential for broader applications in industries that rely on biopharmaceuticals. As he continues to develop new innovations, the scientific community eagerly anticipates the impact of his future endeavors.